Atrial fibrillation (AF) is the most common heart rhythm disorder and is associated with considerable morbidity from ischemic stroke, particularly among older adults.1 Oral anticoagulant (OAC) therapy greatly reduces stroke risk. Despite the evidence against antiplatelet use for stroke prevention, these therapies are often prescribed for AF. However, few have characterized this potentially inappropriate use in older adults.